Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The concentration of GPIbα magnetic particles is a critical parameter occasionally responsible for poor reproducibility of the VWF:GPIbR chemiluminescent immunoassay.
Calcoen B, Van Horenbeeck I, Debasse M, Toelen J, Vanlinthout I, Schoeters J, Peerlinck K, Jacquemin MG. Calcoen B, et al. Among authors: van horenbeeck i. Int J Lab Hematol. 2019 Aug;41(4):e79-e80. doi: 10.1111/ijlh.12970. Epub 2019 Jan 2. Int J Lab Hematol. 2019. PMID: 30600904 No abstract available.
Optimization of the detection of inhibitory autoantibodies against the VWF-cleaving protease ADAMTS13 with an automated chemiluminescent ADAMTS13 activity immunoassay.
Jacquemin M, Van Horenbeeck I, Debasse M, Toelen J, Schoeters J, Vanlinthout I, Peerlinck K, Dierickx D, Van Laer C. Jacquemin M, et al. Among authors: van horenbeeck i. Int J Lab Hematol. 2021 Apr;43(2):290-297. doi: 10.1111/ijlh.13359. Epub 2020 Oct 10. Int J Lab Hematol. 2021. PMID: 33037787
The amplitude of coagulation curves from thrombin time tests allows dysfibrinogenemia caused by the common mutation FGG-Arg301 to be distinguished from hypofibrinogenemia.
Jacquemin M, Vanlinthout I, Van Horenbeeck I, Debasse M, Toelen J, Schoeters J, Lavend'homme R, Freson K, Peerlinck K. Jacquemin M, et al. Among authors: van horenbeeck i. Int J Lab Hematol. 2017 Jun;39(3):301-307. doi: 10.1111/ijlh.12625. Epub 2017 Mar 20. Int J Lab Hematol. 2017. PMID: 28318107 Clinical Trial.
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.
Jacquemin M, Toelen J, Schoeters J, van Horenbeeck I, Vanlinthout I, Debasse M, Peetermans M, Vanassche T, Peerlinck K, van Ryn J, Verhamme P. Jacquemin M, et al. Among authors: van horenbeeck i. J Thromb Haemost. 2015 Nov;13(11):2087-92. doi: 10.1111/jth.13138. Epub 2015 Oct 5. J Thromb Haemost. 2015. PMID: 26347330 Free article.